You are here: Industry Insights > Clinical Trial

News List

NW Bio Announces Deal Worth $47M contractpharma
December 12, 2018
Northwest Biotherapeutics ("NW Bio”) has entered into agreements with a large multi-national corporation for a package transaction involving the Company's property located near Cambridge, UK.
Machine learning tool aims to cut stress in clinical trial patients pharmaphorum
December 05, 2018
Tech firm Cambridge Consultants has designed a digital health tool that aims to make clinical trials more efficient using machine learning to help prevent patients becoming stressed and dropping out.
ChemomAb Appoints Chairman of the Board americanpharmaceuticalreview
December 05, 2018
ChemomAb announced the appointment of Dr. Stephen Squinto as the company’s chairman of the board.In this role, Dr. Squinto will help guide the company ....
Innovent, Hutchison MediPharma in Drug Combo Collaboration contractpharma
December 03, 2018
Innovent Biologics, Inc. a China-based biopharmaceutical company has entered into a global collaboration agreement with Hutchison China MediTech to evaluate the safety and tolerability of Innovent's
Canada clinical trial on personalised medicine for prostate cancer europeanpharmaceuticalreview
November 29, 2018
A clinical trial could be the world’s first to look at personalised medicine in prostate cancer, with patients taking a therapy based on their DNA markers…
Evelo, Merck Enter Clinical Trial Collaboration contractpharma
November 28, 2018
Evelo Biosciences has entered into a clinical trial collaboration agreement with Merck. The collaboration will evaluate EDP1503 in combination with KEYTRUDA® (pembrolizumab),
Natera and Neon Therapeutics Announce Clinical Trial Collaboration pharmafocusasia
November 28, 2018
Natera, Inc., a global leader in cell-free DNA testing, and Neon Therapeutics, Inc., a clinical-stage immuno-oncology company developing neoantigen-based therapeutics.....
Genomic profiling offers hope for rare cancer treatments pharmaceutical-technology
November 14, 2018
A clinical trial led by Walter and Eliza Hall Institute of Medical Research in Australia has demonstrated that genomic profiling could help match rare cancer patients with appropriate treatments.
Genomic profiling offers hope for rare cancer treatments pharmaceutical-technology
November 14, 2018
A clinical trial led by Walter and Eliza Hall Institute of Medical Research in Australia has demonstrated that genomic profiling could help match rare cancer patients with appropriate treatments.
NeuroVive Receives KL1333 Clinical Trial Regulatory Approval americanpharmaceuticalreview
October 12, 2018
NeuroVive Pharmaceutical has received approval of its clinical trial application concerning a planned phase I KL1333 study in patients and healthy volunteers from the UK regulatory authority, Medicines and Healthcare products Regulatory Agency (MHRA).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page